HOPX: A Unique Homeodomain Protein in Development and Tumor Suppression.

Autor: Caspa Gokulan R; Sylvester Comprehensive Cancer Center, Department of Surgery, University of Miami, Miami, FL 33136, USA., Yap LF; Oral Cancer Research Coordinating Centre, Department of Oral and Craniofacial Sciences, Faculty of Dentistry, University of Malaya, Kuala Lumpur 50603, Malaysia., Paterson IC; Oral Cancer Research Coordinating Centre, Department of Oral and Craniofacial Sciences, Faculty of Dentistry, University of Malaya, Kuala Lumpur 50603, Malaysia.; Oral Cancer Research Coordinating Centre, Faculty of Dentistry, University of Malaya, Kuala Lumpur 50603, Malaysia.
Jazyk: angličtina
Zdroj: Cancers [Cancers (Basel)] 2022 Jun 02; Vol. 14 (11). Date of Electronic Publication: 2022 Jun 02.
DOI: 10.3390/cancers14112764
Abstrakt: Homeobox genes are master regulators of morphogenesis and differentiation by acting at the top of genetic hierarchies and their deregulation is associated with a variety of human diseases. They usually contain a highly conserved sequence that codes for the homeodomain of the protein, a specialized motif with three α helices and an N-terminal arm that aids in DNA binding. However, one homeodomain protein, HOPX, is unique among its family members in that it lacks the capacity to bind DNA and instead functions by interacting with transcriptional regulators. HOPX plays crucial roles in organogenesis and is expressed in both embryonic and adult stem cells. Loss of HOPX expression is common in cancer, where it functions primarily as a tumor suppressor gene. In this review, we describe the function of HOPX in development and discuss its role in carcinogenesis.
Databáze: MEDLINE
Nepřihlášeným uživatelům se plný text nezobrazuje